AbbVie Inc. [ABBV] - appoints Dr. John M. Carethers as Director
Effective October 14, 2026, AbbVie Inc. expanded its Board of Directors and appointed Dr. John M. Carethers as a Class II director, who will serve on the Public Policy and Sustainability Committee and is recognized as an independent director.
Why this matters
AbbVie Inc., a Delaware-incorporated pharmaceutical company, is known for its development and sale of pharmaceutical preparations, including treatments for a variety of health conditions. On October 14, 2026, AbbVie expanded its Board of Directors from twelve to thirteen members, appointing Dr. John M. Carethers as a Class II director. Dr. Carethers, who is currently the Vice Chancellor for Health Sciences at the University of California San Diego and has prior experience as a director of Avantor, Inc., will serve on AbbVie's Public Policy and Sustainability Committee. He has been recognized as an independent director according to the New York Stock Exchange standards and AbbVie's governance guidelines.